Aspen Aerogels, Inc. (NYSE:ASPN) Shares Bought by Federated Hermes Inc.

Federated Hermes Inc. increased its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 53.9% in the 4th quarter, HoldingsChannel reports. The firm owned 1,154,042 shares of the construction company’s stock after acquiring an additional 404,042 shares during the quarter. Federated Hermes Inc.’s holdings in Aspen Aerogels were worth $18,211,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Advisor Group Holdings Inc. lifted its stake in shares of Aspen Aerogels by 37.5% in the 1st quarter. Advisor Group Holdings Inc. now owns 2,539 shares of the construction company’s stock valued at $87,000 after purchasing an additional 692 shares during the period. Bank of New York Mellon Corp raised its position in shares of Aspen Aerogels by 7.2% in the first quarter. Bank of New York Mellon Corp now owns 94,868 shares of the construction company’s stock worth $3,271,000 after acquiring an additional 6,356 shares during the period. MetLife Investment Management LLC boosted its stake in shares of Aspen Aerogels by 56.5% during the 1st quarter. MetLife Investment Management LLC now owns 11,713 shares of the construction company’s stock worth $404,000 after acquiring an additional 4,230 shares in the last quarter. Rhumbline Advisers increased its stake in shares of Aspen Aerogels by 13.5% in the 1st quarter. Rhumbline Advisers now owns 22,371 shares of the construction company’s stock valued at $771,000 after purchasing an additional 2,664 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Aspen Aerogels by 5.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 441,247 shares of the construction company’s stock worth $15,214,000 after purchasing an additional 21,112 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

ASPN has been the subject of several research analyst reports. Canaccord Genuity Group upped their target price on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, December 27th. HC Wainwright reiterated a “buy” rating and issued a $20.00 target price on shares of Aspen Aerogels in a research report on Wednesday, February 14th. TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. Canaccord Genuity Group lifted their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, December 27th. Finally, Roth Mkm initiated coverage on Aspen Aerogels in a report on Wednesday, March 6th. They set a “buy” rating and a $22.00 target price for the company. One research analyst has rated the stock with a sell rating and five have issued a buy rating to the company. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $19.00.

Check Out Our Latest Report on Aspen Aerogels

Aspen Aerogels Stock Performance

ASPN opened at $14.96 on Monday. Aspen Aerogels, Inc. has a twelve month low of $5.32 and a twelve month high of $19.10. The firm has a market capitalization of $1.15 billion, a PE ratio of -22.67 and a beta of 2.04. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. The firm’s 50-day moving average price is $16.46 and its 200 day moving average price is $13.10.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. The business had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. Aspen Aerogels had a negative net margin of 19.19% and a negative return on equity of 10.47%. During the same period last year, the company posted ($0.20) EPS. As a group, sell-side analysts expect that Aspen Aerogels, Inc. will post -0.24 EPS for the current fiscal year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.